These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 7937926)

  • 1. Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis.
    Morimoto C; Lord CI; Zhang C; Duke-Cohan JS; Letvin NL; Schlossman SF
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9960-4. PubMed ID: 7937926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity.
    Tanaka T; Kameoka J; Yaron A; Schlossman SF; Morimoto C
    Proc Natl Acad Sci U S A; 1993 May; 90(10):4586-90. PubMed ID: 7685106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells.
    Jacotot E; Callebaut C; Blanco J; Rivière Y; Krust B; Hovanessian AG
    Virology; 1996 Sep; 223(2):318-30. PubMed ID: 8806567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors involved in entry of the human immunodeficiency virus type 1 into permissive cells: lack of evidence of a role for CD26.
    Lazaro I; Naniche D; Signoret N; Bernard AM; Marguet D; Klatzmann D; Dragic T; Alizon M; Sattentau Q
    J Virol; 1994 Oct; 68(10):6535-46. PubMed ID: 7916060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD26/dipeptidyl peptidase IV (CD26/DPPIV) is highly expressed in peripheral blood of HIV-1 exposed uninfected female sex workers.
    Songok EM; Osero B; McKinnon L; Rono MK; Apidi W; Matey EJ; Meyers AF; Luo M; Kimani J; Wachihi C; Ball BT; Plummer FA; Mpoke S
    Virol J; 2010 Nov; 7():343. PubMed ID: 21108831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD26/DPPIV signal transduction function, but not proteolytic activity, is directly related to its expression level on human Th1 and Th2 cell lines as detected with living cell cytochemistry.
    Boonacker EP; Wierenga EA; Smits HH; Van Noorden CJ
    J Histochem Cytochem; 2002 Sep; 50(9):1169-77. PubMed ID: 12185194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative regulation of the anti-human immunodeficiency virus and chemotactic activity of human stromal cell-derived factor 1alpha by CD26/dipeptidyl peptidase IV.
    Ohtsuki T; Hosono O; Kobayashi H; Munakata Y; Souta A; Shioda T; Morimoto C
    FEBS Lett; 1998 Jul; 431(2):236-40. PubMed ID: 9708910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD26 expression correlates with entry, replication and cytopathicity of monocytotropic HIV-1 strains in a T-cell line.
    Oravecz T; Roderiquez G; Koffi J; Wang J; Ditto M; Bou-Habib DC; Lusso P; Norcross MA
    Nat Med; 1995 Sep; 1(9):919-26. PubMed ID: 7585218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of CD26/dipeptidyl peptidase IV on Jurkat sensitivity to G2/M arrest induced by topoisomerase II inhibitors.
    Aytac U; Sato K; Yamochi T; Yamochi T; Ohnuma K; Mills GB; Morimoto C; Dang NH
    Br J Cancer; 2003 Feb; 88(3):455-62. PubMed ID: 12569391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD26/dipeptidyl peptidase IV and its role in cancer.
    Pro B; Dang NH
    Histol Histopathol; 2004 Oct; 19(4):1345-51. PubMed ID: 15375776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorogenic substrate [Ala-Pro]2-cresyl violet but not Ala-Pro-rhodamine 110 is cleaved specifically by DPPIV activity: a study in living Jurkat cells and CD26/DPPIV-transfected Jurkat cells.
    Boonacker E; Elferink S; Bardai A; Fleischer B; Van Noorden CJ
    J Histochem Cytochem; 2003 Jul; 51(7):959-68. PubMed ID: 12810846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma.
    Fasolato S; Trevellin E; Ruvoletto M; Granzotto M; Zanus G; Boscaro E; Babetto E; Terrin L; Battocchio MA; Ciscato F; Turato C; Quarta S; Cillo U; Pontisso P; Vettor R
    Life Sci; 2018 May; 200():134-141. PubMed ID: 29524519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and oncologic implications in epigenetic down-regulation of CD26/dipeptidyl peptidase IV in adult T-cell leukemia cells.
    Tsuji T; Sugahara K; Tsuruda K; Uemura A; Harasawa H; Hasegawa H; Hamaguchi Y; Tomonaga M; Yamada Y; Kamihira S
    Int J Hematol; 2004 Oct; 80(3):254-60. PubMed ID: 15540901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The multifunctional or moonlighting protein CD26/DPPIV.
    Boonacker E; Van Noorden CJ
    Eur J Cell Biol; 2003 Feb; 82(2):53-73. PubMed ID: 12647932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Good or evil: CD26 and HIV infection.
    Ohtsuki T; Tsuda H; Morimoto C
    J Dermatol Sci; 2000 Apr; 22(3):152-60. PubMed ID: 10698152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal cell-derived factor-1alpha-induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma.
    Mizokami Y; Kajiyama H; Shibata K; Ino K; Kikkawa F; Mizutani S
    Int J Cancer; 2004 Jul; 110(5):652-9. PubMed ID: 15146553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human immunodeficiency virus type 1 infection in a T-cell line (CEM) by new dipeptidyl-peptidase IV (CD26) inhibitors.
    Jiang JD; Wilk S; Li J; Zhang H; Bekesi JG
    Res Virol; 1997; 148(4):255-66. PubMed ID: 9272576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26.
    Fletcher MA; Zeng XR; Maher K; Levis S; Hurwitz B; Antoni M; Broderick G; Klimas NG
    PLoS One; 2010 May; 5(5):e10817. PubMed ID: 20520837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipeptidyl peptidase in autoimmune pathophysiology.
    Ohnuma K; Hosono O; Dang NH; Morimoto C
    Adv Clin Chem; 2011; 53():51-84. PubMed ID: 21404914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides.
    Durinx C; Lambeir AM; Bosmans E; Falmagne JB; Berghmans R; Haemers A; Scharpé S; De Meester I
    Eur J Biochem; 2000 Sep; 267(17):5608-13. PubMed ID: 10951221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.